Table 1 Patient characteristics
|  | Type 2 diabetes discovery cohort (n = 49) | Type 1 diabetes validation cohort (n = 50) |
|---|---|---|
Baseline | ||
 Age (years) | 59.0 (10.0) | 44.6 (8.9) |
 Male sex (number (%)) | 39 (80) | 30 (60) |
 SBP (mmHg) | 140.0 (15.4) | 150.6 (17.7) |
 DBP (mmHg) | 81.6 (8.8) | 84.7 (10.9) |
 HbA1c (%) | 8.3 (1.4) | 8.9 (1.2) |
 HbA1c (mmol/mol) | 67.2 (15.3) | 73.8 (13.1) |
 Cholesterol (mmol/l) | 5.3 (1.0) | 5.2 (1.0) |
 HDL (mmol/l) | 1.2 (0.3) | 1.6 (0.5) |
 GFR (ml/min/1.73 m2) | 102.3 (19.2) | 86.5 (23.4) |
 24-h UAE (mg/24 h) | 84 [65, 200] | 1211 [598, 2023] |
Follow-up | ||
 Change in SBP (mmHg) | −6.4 (16.2) | −8.7 (14.3) |
 Change in DBP (mmHg) | −6.0 (8.8) | −5.6 (8.6) |
 Percent change in UAE (%) | −42 % [−69, −8] | −43 % [−62, −23] |
 >30 % decrease in UAE from baseline [number (%)] | 31 (63) | 34 (68) |
 GFR change after response period (mL/min/1.73 m2/year) | Not available | −3.8 (3.6) |